Insulet Corp (PODD)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$200.53
Buy
$206.05
$-2.73 (-1.32%)
Prices updated at 03 Apr 2026, 00:25 EDT
| Prices minimum 15 mins delay
Prices in USD
Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Timothy John Scannell
CEO
Ms. Ashley A. McEvoy
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
5,400
Head office
100 Nagog Park
Acton
United States
01720
Key personnel
Owner name | Salary |
|---|---|
Ms. Elizabeth H. Weatherman Independent Director | 0.08m |
Mr. Michael R. Minogue Independent Director | 0.08m |
Mr. Timothy John Scannell Chairman of the Board | 0.16m |
Dr. Jessica Hopfield, PhD Director | 0.06m |
Mr. Timothy C. Stonesifer Independent Director | 0.06m |
Ms. Ashley A. McEvoy Director, President and Chief Executive Officer | - |
Dr. Wayne A.I. Frederick, M.D. Independent Director | 0.08m |
Dr. Luciana Borio, M.D. Independent Director | 0.07m |
Ms. Flavia H. Pease Executive Vice President, Chief Financial Officer | 0.05m |
Mr. Amit Guliani Group Vice President, Software Engineering and Acting Chief Technology Officer | - |
Mr. Robbie Huffines Director | - |
Mr. John W. Kapples Senior Vice President and General Counsel | 0.50m |
Mr. Eric Benjamin Executive Vice President, Chief Product and Customer Experience Officer | 0.54m |
Ms. Lauren D. Budden Group Vice President, Chief Accounting Officer and Controller | 0.41m |
Mr. Dan Manea Senior Vice President and Chief Human Resources Officer | - |
Mr. Prem Singh Senior Vice President, Global Operations | - |
Ms. Laetitia Cousin Senior Vice President, Regulatory Affairs, Quality Assurance and Compliance | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Vanguard Group Inc | 8,701,472 |
| BlackRock Inc | 6,592,652 |
| FMR Inc | 6,325,354 |
| Fidelity Management and Research Company | 6,325,354 |
| Fidelity Management & Research Company LLC | 4,578,157 |
Director dealings
Date | Action |
|---|---|
| 15 Dec 2025 | - |
| 05 Dec 2025 | - |
| 01 Oct 2025 | - |
| 01 Oct 2025 | - |
| 08 Sep 2025 | - |
| 08 Sep 2025 | - |
| 08 Sep 2025 | - |
| 08 Sep 2025 | - |
| 08 Sep 2025 | - |
| 08 Sep 2025 | - |
| 21 Aug 2025 | - |
| 19 Aug 2025 | - |
| 21 Aug 2025 | - |
| 21 Aug 2025 | - |
| 19 Aug 2025 | - |
| 19 Aug 2025 | - |
| 19 Aug 2025 | - |
| 07 Aug 2025 | - |
| 07 Aug 2025 | - |
| 07 Aug 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
